Aurobindo Pharma Buyback 2024 Latest News Today

September 2, 2024 4:09:18 PM

It is noteworthy that the company invested about Rs. 2,500 Crore to install a Penicillin-G manufacturing plant under the PLI scheme.

August 28, 2024 7:56:00 AM

A sharp rise can be attributed to the significant changes in India's share buyback tax regime, which will come into effect from October 1, 2024.

August 11, 2024 4:39:00 AM

Also Read: Aurobindo Pharma share price rises 6% to 52-week high. Board meeting on 18 July, 2024 to consider share buyback "We are pleased with our continued strong performance this quarter ...

August 16, 2024 6:59:00 PM

Aurobindo Pharma (NS:ARBN) has outperformed expectations in the fourth quarter of FY24, with both sales and EBITDA showing significant year-over-year growth. Sales increased by 17%, while EBITDA ...

August 16, 2024 10:52:00 AM

NEW DELHI: Aurobindo Pharma Ltd on Friday said its arm Eugia Pharma Specialities Ltd received a warning letter from the US health regulator for its formulations manufacturing unit in Telangana.

August 11, 2024 5:54:00 AM

Aurobindo Pharma on Saturday said its consolidated net profit increased 61 per cent year on year to Rs 919 crore in the first quarter ended June 2024, aided by strong sales across markets.

August 12, 2024 2:43:00 AM

Aurobindo Pharma said its consolidated net profit increased 61 per cent year on year to Rs 919 crore in Q1FY25, aided by strong sales across markets, compared to Rs 571 crore in Q1FY24.

August 20, 2024 7:05:00 AM

Aurobindo Pharma reported a 61 per cent increase year-on-year in its consolidated net profit at Rs 919 crore for the April-June quarter this fiscal. The drug maker reported a revenue from ...

September 5, 2024 3:30:00 AM

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

August 19, 2024 10:27:00 PM

Our FY25/26E EPS estimates remains unchanged. Aurobindo Pharma�s (ARBP) Q1FY25 EBITDA of Rs16.2bn (down 4% QoQ) with OPM of 21.4% was marginally below our estimate. We expect margins to further ...

August 11, 2024 4:39:00 AM

Last month, Aurobindo Pharma announced that its board has approved a share buyback plan of up to ?750 crore. The company's board has approved the buyback of up to 51,36,986 shares representing ...